Recent Quotes
View Full List
My Watchlist
Aurora Spine Corp
Benitec Biopharma Inc. - Common Stock
Canary Staked TRX ETF
Castellum, Inc. Common Stock
Clearmind Medicine Inc
Common Units of Beneficial Interest of Morgan Stanley Bitcoin Trust
Cyteir Therapeutics, Inc. - Common Stock
Ferrellgas Partnrs LP New
Jx Holdings Inc Ord
Locafy Limited - Ordinary Share
Metalore Resources Limited
Minehub Technologies Inc
PDF Solutions, Inc. - Common Stock
Paylocity Holding Corporation - Common Stock
PetVivo Holdings, Inc. - Common Stock
Porter & Company Property & Casualty Index ETF
RES. MIN. RADISS
SMX (Security Matters) Public Limited Company - Ordinary Shares
Shuttle Pharmaceuticals Holdings, Inc. - common stock
Southern Co
Spectral Capital Corp
Spruce Power Holding Corporation Class A Common Stock
Sumitomo Mitsui Financial Group Inc
Talphera, Inc. - Common Stock
Vanguard FTSE Dev All Cap Na Idx
Vanguard S&P Small-Cap 600 Growth ETF
Worldline Sa Ord
Xos, Inc. - Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BillionToOne, Inc. - Class A common stock
(NQ:
BLLN
)
98.09
-4.64 (-4.52%)
Delayed Quote
Updated: 1:16 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about BillionToOne, Inc. - Class A common stock
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
October 14, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
October 07, 2026
Head-to-head comparison shows 94% concordance with tumor-informed ctDNA testing, with the clinical ground-truth in all discordant cases supporting Northstar Response
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
August 05, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
July 15, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
May 27, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
May 06, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
April 15, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
March 04, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
February 17, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Provides Guidance for 2026
January 12, 2026
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Reports Third Quarter 2025 Results
December 09, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
December 02, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 07, 2025
From
BillionToOne, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.